117299-99-7

Upstream product

• 57783-73-0 methyl 3,4-di-O-benzyl-α-D-mannopyranoside 
• 74-88-4 methyl iodide 

Downstream Products

• 117300-03-5 3,4-di-O-benzyl-2,6-di-O-methyl-α-D-mannopyranose 
• 117300-04-6 3,4-di-O-benzyl-2,6-di-O-methyl-β-D-mannopyranose 
• 117300-02-4 3,4-di-O-benzyl-2-O-methyl-α-L-lyxopyranosyl 3,4-di-O-benzyl-2,6-di-O-methyl-α-D-mannopyranoside 
• 117300-02-4 3,4-di-O-benzyl-2-O-methyl-α-L-lyxopyranosyl 3,4-di-O-benzyl-2,6-di-O-methyl-β-D-mannopyranoside 
• 117325-10-7 3,4-di-O-benzyl-2,6-di-O-methyl-α-D-mannopyranosyl chloride 
• 117300-00-2 Acetic acid (2R,3S,4S,5R,6R)-4,5-bis-benzyloxy-3-methoxy-6-methoxymethyl-tetrahydro-pyran-2-yl ester 

Relevant academic research and scientific papers

SYNTHESIS OF EVERNINOSE, A NON-REDUCING DISACCHARIDE COMPONENT OF THE ORTHOSOMYCIN-TYPE OLIGOSACCHARIDE ANTIBIOTICS

Glycosylation of 3,4-di-O-benzyl-2-O-methyl-L-lyxopyranose (1) with 3,4-di-O-benzyl-2,6-di-O-methyl-α-D-mannopyranosyl chloride afforded a mixture of the α,α- 12) and α,β-disaccharide derivative (10).Reaction of 1 with 3,4-di-O-benzyl-2,6-di-O-methyl-α-D-